Free Trial

Veradigm (NASDAQ:MDRX) Shares Pass Above Two Hundred Day Moving Average - Here's Why

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. (NASDAQ:MDRX) shares have crossed above their 200-day moving average, currently trading at $4.80 with a high of $4.85 during Tuesday's session.
  • Analysts have issued a "hold" rating on the stock, with an average target price set at $13.00, indicating potential room for growth despite the current trading level.
  • Veradigm provides various healthcare technology solutions including electronic health records and population health management services to organizations across North America and internationally.
  • Looking to export and analyze Veradigm data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $4.61 and traded as high as $4.85. Veradigm shares last traded at $4.80, with a volume of 186,613 shares traded.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen started coverage on Veradigm in a report on Tuesday, May 20th. They issued a "hold" rating for the company. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $13.00.

View Our Latest Report on MDRX

Veradigm Price Performance

The firm has a 50 day moving average price of $4.69 and a two-hundred day moving average price of $4.61.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines